aap Implantate AG (AAQ1) - Cash Flow Conversion Efficiency

Latest as of June 2022: -0.052x

Based on the latest financial reports, aap Implantate AG (AAQ1) has a cash flow conversion efficiency ratio of -0.052x as of June 2022. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-659.50K ≈ $-771.02K USD) by net assets (€12.63 Million ≈ $14.77 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See aap Implantate AG balance sheet quality to measure how much of total assets are equity-financed.

aap Implantate AG - Cash Flow Conversion Efficiency Trend (2016–2024)

This chart illustrates how aap Implantate AG's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore aap Implantate AG cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.

aap Implantate AG Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of aap Implantate AG ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
S2 Resources Ltd AU:S2R	-0.100x
Warimpex Finanz- und Beteiligungs AG VI:WXF	0.093x
Censof Holdings Bhd KLSE:5195	0.051x
Eupe Corporation Bhd KLSE:6815	0.111x
Caravelle International Group NASDAQ:HTCO	-0.150x
DDC Enterprise Limited NYSE:DDC	-0.359x
Adval Tech Holding AG SW:ADVN	0.045x
DigitalX Limited F:VSL	-0.021x

Annual Cash Flow Conversion Efficiency for aap Implantate AG (2016–2024)

The table below shows the annual cash flow conversion efficiency of aap Implantate AG from 2016 to 2024. For the full company profile with market capitalisation and key ratios, see AAQ1 market cap.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	€10.46 Million ≈ $12.23 Million	€-1.12 Million ≈ $-1.31 Million	-0.107x	+70.14%
2023-12-31	€8.10 Million ≈ $9.47 Million	€-2.92 Million ≈ $-3.41 Million	-0.360x	-143.82%
2022-12-31	€12.83 Million ≈ $15.00 Million	€-1.89 Million ≈ $-2.21 Million	-0.148x	+23.67%
2021-12-31	€12.78 Million ≈ $14.94 Million	€-2.47 Million ≈ $-2.89 Million	-0.193x	+45.86%
2020-12-31	€10.29 Million ≈ $12.03 Million	€-3.67 Million ≈ $-4.30 Million	-0.357x	-16.83%
2019-12-31	€18.87 Million ≈ $22.06 Million	€-5.77 Million ≈ $-6.74 Million	-0.306x	-80.31%
2018-12-31	€34.92 Million ≈ $40.82 Million	€-5.92 Million ≈ $-6.92 Million	-0.170x	-32.90%
2017-12-31	€42.56 Million ≈ $49.76 Million	€-5.43 Million ≈ $-6.35 Million	-0.128x	+3.01%
2016-12-31	€54.78 Million ≈ $64.04 Million	€-7.20 Million ≈ $-8.42 Million	-0.131x	--

About aap Implantate AG

F:AAQ1 Germany Medical Devices

Market Cap

$26.32 Million

€22.52 Million EUR

Market Cap Rank

#24159 Global

#2090 in Germany

Share Price

€1.53

Change (1 day)

+2.00%

52-Week Range

€1.27 - €2.22

All Time High

€21.70